(Q43078073)

English

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

scientific article published on 28 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

based on heuristic

inferred from title

Emanuele Montomoli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Filippo Ansaldi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marta Zancolli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Paolo Durando

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Laura Sticchi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Giuseppe Del Giudice

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Giancarlo Icardi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

28 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4123-4129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20433807%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Quantifying influenza vaccine efficacy and antigenic distance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.030

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43078073&oldid=1592095206"